Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
批准号:
7602965
负责人:
VOLNEY L SHEEN
金额:
$25.5万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-04 至 2011-03-31
关键词:
ARNT2 geneAdoptedAgeAlzheimer&aposs DiseaseAmyloid beta-Protein PrecursorBrainCalcium-Binding ProteinsCell DeathCell LineCharacteristicsChromosomes, Human, Pair 21Congenital AbnormalityCongenital Heart DefectsDataDefectDevelopmentDiseaseDown SyndromeFaceFinancial compensationFree RadicalsGene DuplicationGene ExpressionGene Expression ProfileGenesGenomeGoalsHIF1A geneHearing problemHumanHuman BiologyHuman IdentificationsIn VitroIndividualInfectionInjuryIntervention StudiesLeadMediatingMental RetardationMessenger RNAModelingMolecularMolecular ProfilingNetwork-basedNeurologicNeuronsPathway AnalysisPathway interactionsPhenotypeProcessProteinsReactive Oxygen SpeciesSamplingSeizuresTechniquesTechnologyTestingTherapeutic InterventionTissuesUp-RegulationVisionaquaporin 4brain tissuecell typedevelopmental diseasegenome-widehuman stem cellsinsightmRNA Expressionmouse Trisomy 16mouse modelnerve stem cellnew therapeutic targetnormal agingprematureprogenitorpublic health relevanceresponsestem cell populationwater channel
中文摘要
描述(申请人提供):唐氏综合症(DS)是一种常见的发育障碍,由21号染色体重复引起。了解导致DS的主要神经学特征的发育机制,即MR、癫痫和早产儿阿尔茨海默病(AD),将取决于DS与正常大脑在发育过程中观察到的差异的特征。不同的小鼠模型被用作理解这种差异的实验范式,但这些研究的解释存在明显的局限性,特别是因为人类大脑的生物学与其他物种的不同。此外,DS脑的许多神经病理特征,即细胞增殖、细胞死亡和神经元发生的改变,表明神经干细胞(NSC)群体中存在缺陷。因此,我们建议研究从唐氏综合征脑来源的人神经干细胞的mRNA谱,并表征在这一体外发育模型中被破坏的细胞和分子因素。我们假设,人类DS NSCs中21号染色体上基因表达的改变将导致整个基因组中可识别的mRNA表达变化,并且这些变化可能与特定的功能途径有关,这些途径将有助于DS CNS表型。我们提出了一项涉及人类DS神经前体细胞的两部分研究,以探讨DS皮质发育的机制:具体目标1:使用经过验证的定量mRNA图谱技术,我们将识别与年龄匹配的对照相比,多个人类DS神经前体细胞系的mRNA表达谱上的基因变化,并使用网络分析来确定相互作用的蛋白质和对DS重要的发育途径。具体目标2:我们将测试在先前目标中预测的功能变化是否在DS NSCs和人类或16三体小鼠组织中明显。通过对相当均匀的人DS神经前体细胞的定量mRNA分析和对DS神经前体细胞的体外功能分析,我们希望对这种常见疾病的发病机制有更深入的了解,并为发现新的治疗靶点提供潜在的场所。公共卫生相关性唐氏综合症(DS)是人类最常见的发育障碍之一,由21号染色体上基因的异常复制引起。目前的提议寻求从DS脑中产生和研究人类干细胞。了解这种疾病中被破坏的基因将有助于开发治疗干预措施。
英文摘要
DESCRIPTION (provided by applicant): Down syndrome (DS) is a common developmental disorder caused by a duplication of chromosome 21. Understanding the developmental mechanisms that lead to the primary neurological features of DS, namely MR, seizures, and premature Alzheimer's disease (AD), will depend upon characterization of the differences observed in the development of the DS, as opposed to normal brain. Various mouse models have been used as experimental paradigms to understand such differences, but clear limitations exist in the interpretation of these studies, particularly since the biology of human brains are different from those of other species. Moreover, many of the neuropathological features of DS brain namely altered proliferation, cell death, and neuronogenesis suggest a defect within the neural stem cell (NSC) population. Thus, we propose to investigate the mRNA profiles of human NSCs derived from Down syndrome brain and characterize the cellular and molecular factors which are disrupted in this vitro developmental model. We hypothesize that altered expression of genes on chromosome 21 in human DS NSCs will lead to identifiable mRNA expression changes throughout the genome, and that these changes can be associated with specific functional pathways that will contribute to the DS CNS phenotype. We propose a two-part study involving human DS neural progenitors, to investigate the mechanisms of DS cortical development: Specific Aim 1: Using validated techniques of quantitative mRNA profiling technology, we will identify genes altered on mRNA expression profiles of multiple human DS neural progenitor lines as compared to age-matched controls and use network analysis to identify interacting proteins and developmental pathways important for DS. Specific Aim 2: We will test whether the functional changes predicted in the prior aim are apparent in the DS NSCs and human or trisomy 16 mouse tissues. Through quantitative mRNA analyses of fairly uniform human DS neural progenitors and functional analyses of DS neural precursors in vitro, we hope to gain additional insight into mechanisms underlying this common disorder and provide potential venues for the discovery of new therapeutic targets. PUBLIC HEALTH RELEVANCE Down Syndrome (DS) is one of the most common developmental disorders in humans and is caused by the abnormal duplication of genes on chromosome 21. The current proposal seeks to generate and study human stem cells from DS brain. Understanding the genes which are disrupted in this disorder will allow for the development of therapeutic interventions.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3791/2681
发表时间:
2011-05-25
期刊:
Journal of visualized experiments : JoVE
影响因子:
--
作者:
[Lu, Jie, Delli-Bovi, Laurent C, Sheen, Volney L]
通讯作者:
Sheen, Volney L
DOI:
10.1021/bm201372u
发表时间:
2012-02-13
期刊:
BIOMACROMOLECULES
影响因子:
6.2
作者:
[Cai, Lei, Lu, Jie, Sheen, Volney, Wang, Shanfeng]
通讯作者:
Wang, Shanfeng
Seizure or syncope: lessons over time.
癫痫发作或晕厥:随着时间的推移吸取教训。
DOI:
10.1016/j.jocn.2011.06.017
发表时间:
2012
期刊:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
影响因子:
--
作者:
[Sheen,VolneyL]
通讯作者:
Sheen,VolneyL
DOI:
10.1111/j.1582-4934.2008.00159.x
发表时间:
2008-06
期刊:
Journal of cellular and molecular medicine
影响因子:
5.3
作者:
[Esposito G, Scuderi C, Lu J, Savani C, De Filippis D, Iuvone T, Steardo L Jr, Sheen V, Steardo L]
通讯作者:
Steardo L
Optimal poly(L-lysine) grafting density in hydrogels for promoting neural progenitor cell functions.
DOI:
10.1021/bm300381d
发表时间:
2012-05-14
期刊:
BIOMACROMOLECULES
影响因子:
6.2
作者:
[Cai, Lei, Lu, Jie, Sheen, Volney, Wang, Shanfeng]
通讯作者:
Wang, Shanfeng
共 8 条
Down Syndrome: a potential treatment XISTs
-
批准号:10525816
-
项目类别:
-
资助金额:$169.33万
-
财政年份:2022
-
负责人:VOLNEY L SHEEN
-
依托单位:
Epigenetic Silencing of HSA21 in Down Syndrome
-
批准号:10016836
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Deciphering HSA21 genes associated with Alzheimers disease in Down Syndrome
-
批准号:10120793
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Epigenetic Silencing of HSA21 in Down Syndrome
-
批准号:9892127
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2019
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8269069
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:7729307
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8078196
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Cellular and Molecular Mechanisms in Periventricular Heterotopia
-
批准号:8470253
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2009
-
负责人:VOLNEY L SHEEN
-
依托单位:
Human Neural Precursors from CNS Developmental Disorders: Down Syndrome
-
批准号:7470915
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2008
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6361362
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6755157
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6896101
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6539295
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
The Role of Filamin in Periventricular Heterotopias
-
批准号:6608616
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2001
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2430901
-
项目类别:
-
资助金额:$0.14万
-
财政年份:1997
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2242517
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1996
-
负责人:VOLNEY L SHEEN
-
依托单位:
LOCAL MICROENVIRONMENTAL CONTROL OF NEURAL SPECIFICATION
-
批准号:2242516
-
项目类别:
-
资助金额:$2.35万
-
财政年份:1995
-
负责人:VOLNEY L SHEEN
-
依托单位:
海外基金